Ledger.Open graph →
SEC Form D · filed May 24, 2016

Galena Biopharma, Inc

Offering
$24.0M
Sold
$24.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Ramon, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Mark W. Schwartz, Ph.D · Portland, ORDirectorWilliam L. Ashton · Portland, ORDirectorSanford J. Hillsberg · Portland, ORDirectorRudolph J. Nisi, M.D · San Ramon, CADirectorRichard L. Chin, M.D · Portland, ORDirectorBijan J. Nejadnik, M.D · San Ramon, CAExecStephen M. Galliker · San Ramon, CADirectorSteven A. Kriegsman · Portland, ORDirectorMary A. Gray, Ph.D · San Ramon, CADirectorThomas J. Knapp · San Ramon, CAExecIrving M. Einhorn · San Ramon, CADirectorMark W. Schwartz, Ph.D · Portland, ORDirectorWilliam L. Ashton · Portland, ORDirectorSanford J. Hillsberg · Portland, ORDirectorRudolph J. Nisi, M.D · San Ramon, CADirectorRichard L. Chin, M.D · Portland, ORDirectorBijan J. Nejadnik, M.D · San Ramon, CAExecStephen M. Galliker · San Ramon, CADirectorSteven A. Kriegsman · Portland, ORDirectorMary A. Gray, Ph.D · San Ramon, CADirectorThomas J. Knapp · San Ramon, CAExecIrving M. Einhorn · San Ramon, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗